Second Panel on Cost-Effectiveness in Health and Medicine

The Second Panel on Cost-Effectiveness in Health and Medicine was formed in 2012 to review the current status of the field of cost-effectiveness analysis and developed a new set of recommendations. Find out more about major changes made here. (Source: The Journal of the American Medical Association, 9/13/16)

You might also be interested in:

Government, Big Pharma, and The People: A Century of Dis-Ease 12/03/2020
The ISPOR Health Economics and Outcomes Research Competencies… 09/22/2020
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Association for Accessible Medicines (AAM) Names Health Care… 08/25/2020
[Webinar] How can VA/HTA Inform Policy Interventions and… 10/15/2020
Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
Key Innovations Coming From The Next Generation of PBM’s 08/12/2020